GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,883,000 | +15.2% | 22,517 | -38.7% | 0.01% | +7.7% |
| Q4 2020 | $4,240,000 | +42.7% | 36,747 | +20.3% | 0.01% | +30.0% |
| Q3 2020 | $2,972,000 | -5.2% | 30,534 | +19.5% | 0.01% | -16.7% |
| Q2 2020 | $3,135,000 | +37.9% | 25,551 | -1.6% | 0.01% | +9.1% |
| Q1 2020 | $2,273,000 | -18.0% | 25,963 | -2.1% | 0.01% | 0.0% |
| Q4 2019 | $2,771,000 | +1.0% | 26,507 | +11.1% | 0.01% | -8.3% |
| Q3 2019 | $2,744,000 | -29.7% | 23,861 | +5.4% | 0.01% | -29.4% |
| Q2 2019 | $3,903,000 | +15.3% | 22,644 | +12.7% | 0.02% | +6.2% |
| Q1 2019 | $3,386,000 | +61.6% | 20,091 | -6.6% | 0.02% | +45.5% |
| Q4 2018 | $2,095,000 | -36.5% | 21,518 | +12.6% | 0.01% | -31.2% |
| Q3 2018 | $3,300,000 | +52.6% | 19,106 | +23.3% | 0.02% | +45.5% |
| Q2 2018 | $2,163,000 | +85.0% | 15,500 | +49.3% | 0.01% | +83.3% |
| Q1 2018 | $1,169,000 | +26.4% | 10,383 | +48.2% | 0.01% | +20.0% |
| Q4 2017 | $925,000 | – | 7,007 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|